S3Inject
S3Inject
Millions of injections are administered every year, for a variety of aesthetic and therapeutic purposes — from dermal fillers, to analgesia, to diagnostic aspirations. Despite the frequency of these procedures, they can still involve considerable risk and variability. The technology in development at S3Inject has the potential to transform the outcomes of these essential procedures for both injectors and patients alike.
Novel injection targeting system
Aesthetic injectables:
Innovation Studio
Clinical Evaluation
Pre-Commercial
On Market
Medical injectables:
Innovation Studio
Clinical Evaluation
Pre-Commercial
On Market
Vascular access:
Innovation Studio
Clinical Evaluation
Pre-Commercial
On Market
With over 3.5 million dermal filler procedures worldwide each year, every needle still represents a risk to be mitigated. Since typical injection areas for fillers are highly vascularized, puncturing and injecting into a blood vessel remains a concern for even experienced injectors.
To mitigate that risk, we’ve developed a new “smart” needle system in development at S3Inject: a platform injection technology that can differentiate connective tissue, fat, blood vessels, and muscle. An ideal sensing system for targeted filler injections, it also has the potential to improve aspiration precision and avoidance of critical areas in a wide range of procedures.
With no retraining requirements and a modular design that can be fitted to a variety of needles or cannulas, this new injection targeting system promises to be a significant advance for many different practitioners — and a competitive advantage for many injectable products.